Corrigendum to "Gypenoside XLIX attenuates sepsis-induced splenic injury through inhibiting inflammation and oxidative stress" [Int. Immunopharmacol. 127 (2024) 111420
| Errataetall: |
ErratumFor: Int Immunopharmacol. 2024 Jan 25;127:111420. - PMID 38142642 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:131 |
|---|---|
| Enthalten in: |
International immunopharmacology - 131(2024) vom: 20. Apr., Seite 111694 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Xu, Baoshi [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 09.04.2024 published: Print-Electronic ErratumFor: Int Immunopharmacol. 2024 Jan 25;127:111420. - PMID 38142642 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.intimp.2024.111694 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368583015 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368583015 | ||
| 003 | DE-627 | ||
| 005 | 20240409232448.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240218s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.intimp.2024.111694 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1370.xml |
| 035 | |a (DE-627)NLM368583015 | ||
| 035 | |a (NLM)38368241 | ||
| 035 | |a (PII)S1567-5769(24)00212-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Xu, Baoshi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Corrigendum to "Gypenoside XLIX attenuates sepsis-induced splenic injury through inhibiting inflammation and oxidative stress" [Int. Immunopharmacol. 127 (2024) 111420 |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 09.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumFor: Int Immunopharmacol. 2024 Jan 25;127:111420. - PMID 38142642 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Yang, Rongrong |e verfasserin |4 aut | |
| 700 | 1 | |a Qiang, Jingchao |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Xuhui |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Mengyuan |e verfasserin |4 aut | |
| 700 | 1 | |a Ji, Xiaomeng |e verfasserin |4 aut | |
| 700 | 1 | |a Lu, Yingzhi |e verfasserin |4 aut | |
| 700 | 1 | |a Dong, Zibo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International immunopharmacology |d 2001 |g 131(2024) vom: 20. Apr., Seite 111694 |w (DE-627)NLM112639542 |x 1878-1705 |7 nnns |
| 773 | 1 | 8 | |g volume:131 |g year:2024 |g day:20 |g month:04 |g pages:111694 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.intimp.2024.111694 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 131 |j 2024 |b 20 |c 04 |h 111694 | ||